Showing results (41-50 of 702) with videos related to
Sort By:
Pageof 71
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|July 19, 2011
Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort studyPeter Vestergaard, Kristoffer Schwartz, Lars Rejnmark, et al.Calcified Tissue International|March 24, 2010
Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort studyPeter Vestergaard, Kristoffer Schwartz, Else Marie Pinholt, et al.Calcified Tissue International|September 24, 2010
Effects of smoking on severity of disease in primary hyperparathyroidismAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.Calcified Tissue International|December 4, 2009
Gastric and esophagus events before and during treatment of osteoporosisPeter Vestergaard, Kristoffer Schwartz, Else Marie Pinholt, et al.Current Drug Safety|April 29, 2011
New and emerging antiresorptive treatments in osteoporosisLars Rejnmark, Leif MosekildeEuropean Journal of Endocrinology|May 1, 2002
Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolismLars Rejnmark, Anna L Lauridsen, Peter Vestergaard, et al.Ugeskrift for Laeger|April 18, 2007
[Vitamin D and breast cancer]Lars Rejnmark Nielsen, Leif MosekildeCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyLars Rejnmark, Anna Tietze, Peter Vestergaard, et al.Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.Pageof 71